文献速递前列腺癌

一种用于检测前列腺癌盆腔淋巴结转移的非侵入性25基因PLNM评分尿液检测

A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-02-02

研究基于多中心回顾性队列(n=413)训练和独立多中心前瞻性队列(n=243)验证,开发了25基因PLNM评分尿液检测算法,在回顾性和前瞻性队列中区分PLNM的AUC分别为0.93(95%CI:0.85-1.01)和0.93(95%CI:0.87-0.99),并可分别避免96%和80%的不必要盆腔淋巴结清扫,仅遗漏0.51%和1%的PLNM。

要点

  • 25基因PLNM评分尿液检测在回顾性和前瞻性队列中区分PLNM的AUC均为0.93。
  • 该检测可分别避免96%和80%的不必要盆腔淋巴结清扫,仅遗漏0.51%和1%的PLNM。
  • MSKCC评分仅避免15%的盆腔淋巴结清扫,遗漏0%的PLNM。

核心结论

  • 新型25基因PLNM评分是首个基于机器学习算法的高精度非侵入性尿液检测,可在盆腔淋巴结清扫前识别PLNM,具有避免不必要清扫和改善治疗决策的潜在临床获益。

研究设计与样本

  • 采用先进随机森林机器学习算法筛选,使用多中心回顾性队列(n=413)尿液样本作为训练集开发分类器,并在独立多中心前瞻性队列(n=243)中验证。

主要发现

  • 25基因PLNM评分在回顾性尿液队列中区分PLNM与非PLNM的AUC为0.93(95%CI:0.85-1.01),在前瞻性队列中为0.93(95%CI:0.87-0.99)。
  • 按25基因PLNM评分分层的患者,生化复发无生存期和远处转移无生存期差异显著(log rank P < 0.001 和 P < 0.0001)。
  • 该检测在回顾性队列中避免96%的不必要盆腔淋巴结清扫,仅遗漏0.51%的PLNM;在前瞻性队列中避免80%的不必要清扫,仅遗漏1%的PLNM。
  • MSKCC评分仅避免15%的盆腔淋巴结清扫,遗漏0%的PLNM。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate cancer patients with pelvic lymph node metastasis (PLNM) have poor prognosis. Based on EAU guidelines, patients with >5% risk of PLNM by nomograms often receive pelvic lymph node dissection (PLND) during prostatectomy. However, nomograms have limited accuracy, so large numbers of false positive patients receive unnecessary surgery with potentially serious side effects. It is important to accurately identify PLNM, yet current tests, including imaging tools are inaccurate. Therefore, we intended to develop a gene expression-based algorithm for detecting PLNM. METHODS: An advanced random forest machine learning algorithm screening was conducted to develop a classifier for identifying PLNM using urine samples collected from a multi-center retrospective cohort (n = 413) as training set and validated in an independent multi-center prospective cohort (n = 243). Univariate and multivariate discriminant analyses were performed to measure the ability of the algorithm classifier to detect PLNM and compare it with the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram score. RESULTS: An algorithm named 25 G PLNM-Score was developed and found to accurately distinguish PLNM and non-PLNM with AUC of 0.93 (95% CI: 0.85-1.01) and 0.93 (95% CI: 0.87-0.99) in the retrospective and prospective urine cohorts respectively. Kaplan-Meier plots showed large and significant difference in biochemical recurrence-free survival and distant metastasis-free survival in the patients stratified by the 25 G PLNM-Score (log rank P < 0.001 and P < 0.0001, respectively). It spared 96% and 80% of unnecessary PLND with only 0.51% and 1% of PLNM missing in the retrospective and prospective cohorts respectively. In contrast, the MSKCC score only spared 15% of PLND with 0% of PLNM missing. CONCLUSIONS: The novel 25 G PLNM-Score is the first highly accurate and non-invasive machine learning algorithm-based urine test to identify PLNM before PLND, with potential clinical benefits of avoiding unnecessary PLND and improving treatment decision-making.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Guo J, Gu L, Johnson H, et al. A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis. Prostate Cancer Prostatic Dis. 2024. PMID: 38308042. doi:10.1038/s41391-023-00758-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。